Today: 19 March 2026
Subscribe
Browse Category

Stock Market 22 December 2025

Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks shares rose 1.5% to $189.65 on Dec. 22 after news of an expanded Google Cloud partnership, reportedly worth nearly $10 billion over several years. The deal includes integrating Palo Alto’s AI security tools with Google Cloud services and expanding firewall and SASE deployments. Analysts highlighted the partnership’s potential to drive recurring revenue but noted execution risks remain.
22 December 2025
····
Rocket Lab (RKLB) Stock Surges on $816M Space Force Satellite Contract and Record 2025 Launches — What News and Forecasts Say on Dec. 22, 2025

Rocket Lab (RKLB) Stock Surges on $816M Space Force Satellite Contract and Record 2025 Launches — What News and Forecasts Say on Dec. 22, 2025

Rocket Lab shares climbed to new highs on Monday, Dec. 22, 2025, after the company announced an $816 million U.S. Space Development Agency contract to build 18 missile-tracking satellites. The stock gained mid-to-high single digits after an 18% rally Friday, fueled by the contract and a record year of Electron launches. The deal could reach $1 billion if Rocket Lab supplies subsystems to other contractors.
22 December 2025
···
ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow shares traded at $156.25 as of 17:00 UTC, up 0.6% after a 5-for-1 stock split took effect Dec. 18. The company completed its acquisition of Moveworks and is in reported talks to buy cybersecurity firm Armis for up to $7 billion. Shares fell over 11% on Dec. 15 after the Armis news surfaced. Analyst concerns focus on deal size and growth strategy.
22 December 2025
·
IonQ Stock (IONQ) Surges as Quantum Rebound Gathers Steam: Latest News, Analyst Forecasts, and Key Risks (Dec. 22, 2025)

IonQ Stock (IONQ) Surges as Quantum Rebound Gathers Steam: Latest News, Analyst Forecasts, and Key Risks (Dec. 22, 2025)

IonQ shares jumped 13.6% to $55.06 as of 17:20 UTC on Dec. 22, 2025, trading on heavy volume with no single news catalyst. The move followed new analyst coverage, including a Jefferies Buy rating and $100 target and a Wedbush Outperform at $60. Consensus targets remain widely dispersed, ranging from $30 to $100.
22 December 2025
···
Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

Goldman Sachs shares traded near $903 by midday Monday, within 2% of their 52-week high, after a year of strong gains driven by robust dealmaking and client activity. Reuters data shows Goldman led investment banking fees in EMEA in 2025 with a 6.8% share. The bank’s next earnings report is due January 15, 2026. Analyst price targets remain below current stock levels.
22 December 2025
·
AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie shares traded at $227.73 midday Monday, near recent highs, as the company remains one of three major drugmakers not signed onto the White House’s new “most-favored-nation” drug-pricing agreements announced December 19. Investors are watching for AbbVie’s next move on the policy front, while its core immunology drugs and dividend growth continue to anchor fundamentals.
22 December 2025
···
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen shares rose to around $331 on December 22, 2025, after the White House announced drug-pricing deals with major drugmakers, including Amgen. The company will offer Aimovig and Amjevita at $299 per month through direct-to-patient sales. Analysts said the agreements may ease tariff and political risks but are unlikely to significantly affect pharma profits in the near term.
22 December 2025
··
Quantum Computing Inc (QUBT) Stock News Today: Why Shares Jumped on Dec. 22, 2025 — and What Analysts Forecast Next

Quantum Computing Inc (QUBT) Stock News Today: Why Shares Jumped on Dec. 22, 2025 — and What Analysts Forecast Next

Quantum Computing Inc. shares jumped 13.8% to $12.39 on Dec. 22, 2025, with trading volume exceeding 17 million shares despite no clear news catalyst. The company disclosed a $110 million cash agreement to acquire Luminar Semiconductor through a bankruptcy court process, with a March 31, 2026, deadline for closing.
22 December 2025
····
Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals joined the Nasdaq-100 Index on Dec. 22, 2025, as the annual reconstitution took effect before the market opened. Shares traded near $405.60, up 1.3% from the prior close. The company recently announced a $250 million U.S. manufacturing expansion and reported strong adoption of its AMVUTTRA therapy for transthyretin amyloidosis.
22 December 2025
···
Johnson & Johnson Stock (JNJ) News Today: Latest Updates, Analyst Forecasts, and What Could Move Shares Next (Dec. 22, 2025)

Johnson & Johnson Stock (JNJ) News Today: Latest Updates, Analyst Forecasts, and What Could Move Shares Next (Dec. 22, 2025)

Johnson & Johnson shares traded at $206.63 Monday after the European Commission approved TREMFYA for pediatric psoriasis, marking its first IL-23 inhibitor indication in children. The company also secured recent FDA approvals for RYBREVANT FASPRO in lung cancer and TRUFILL n-BCA for chronic subdural hematoma. Ongoing talc litigation continues to affect investor sentiment.
22 December 2025
·
Monolithic Power Systems (MPWR) Stock on Dec. 22, 2025: Nasdaq-100 Debut, Analyst Targets, Dividend, and Fresh Technical Signals

Monolithic Power Systems (MPWR) Stock on Dec. 22, 2025: Nasdaq-100 Debut, Analyst Targets, Dividend, and Fresh Technical Signals

Monolithic Power Systems joined the Nasdaq-100 Index before the market opened Monday, Dec. 22, 2025. Shares traded near $958.73, up 2.3% on the day, with a session range of $949.33 to $970.00. Analysts maintain a “Buy” consensus, with a 12-month average target of $1,196. The company declared a $1.56 quarterly dividend, payable Jan. 15, 2026.
22 December 2025
···
Exxon Mobil (XOM) Stock News Today: Fresh Catalysts, Analyst Forecasts, and What to Watch on December 22, 2025

Exxon Mobil (XOM) Stock News Today: Fresh Catalysts, Analyst Forecasts, and What to Watch on December 22, 2025

Exxon Mobil shares traded near $118 on Dec. 22, 2025, as investors assessed steady oil prices and the company’s updated 2030 growth plan. Exxon projects $25 billion in earnings growth and $35 billion in cash flow by 2030, with no increase in capital spending. A CFO transition is set for February 2026. Guyana and the Permian Basin remain key project areas.
22 December 2025
··
UniFirst Corporation Stock (UNF) Jumps After Cintas Renews $275 Buyout Offer — News, Forecasts, and What’s Next

UniFirst Corporation Stock (UNF) Jumps After Cintas Renews $275 Buyout Offer — News, Forecasts, and What’s Next

Cintas Corporation made a $5.2 billion all-cash offer to acquire UniFirst at $275 per share, its third attempt to buy the company. UniFirst confirmed receipt of the non-binding proposal and said its board is reviewing the bid. UniFirst shares jumped 18% to $201 after the news, well below the offer price. Cintas included a $350 million reverse termination fee if regulators block the deal.
22 December 2025
···
Salesforce (CRM) Stock News Today: Latest Headlines, Analyst Forecasts, and Agentforce AI Outlook (December 22, 2025)

Salesforce (CRM) Stock News Today: Latest Headlines, Analyst Forecasts, and Agentforce AI Outlook (December 22, 2025)

Salesforce shares traded near $263 on December 22, 2025, valuing the company in the mid-$200 billion range. The stock is up 14.4% over the past four weeks amid upward earnings revisions, with fiscal 2026 EPS consensus at $11.67. Q3 results showed $10.3 billion in revenue and a 35.5% non-GAAP operating margin. Investors remain focused on AI monetization and institutional positioning.
22 December 2025
··
Applied Optoelectronics (AAOI) Stock Jumps on 800G Hyperscaler Momentum: Dec. 22, 2025 News, Analyst Forecasts, and Outlook

Applied Optoelectronics (AAOI) Stock Jumps on 800G Hyperscaler Momentum: Dec. 22, 2025 News, Analyst Forecasts, and Outlook

Applied Optoelectronics shares jumped 14% to 16% intraday Monday, trading near $36, after news of its first volume order for 800G data center transceivers from a major hyperscale customer. The company expects 800G shipments to add $4 million to $8 million in Q4 revenue. AAOI also reported $22 million in 400G orders year-to-date.
22 December 2025
···
CoreWeave Stock (NASDAQ: CRWV) News Today: DOE “Genesis Mission” Boost Meets Debt Fears, Analyst Targets, and a Make‑or‑Break 2026 Narrative (Dec. 22, 2025)

CoreWeave Stock (NASDAQ: CRWV) News Today: DOE “Genesis Mission” Boost Meets Debt Fears, Analyst Targets, and a Make‑or‑Break 2026 Narrative (Dec. 22, 2025)

CoreWeave shares climbed about 3%–4% to the mid-$80s Monday, extending Friday’s surge after news it joined the U.S. Department of Energy’s Genesis Mission. Volume topped 13 million shares by late morning. The stock remains volatile, with investors weighing government AI ties against concerns over leverage and customer concentration.
22 December 2025
·
1 … 823 824 825 826 827 … 1,354

Stock Market Today

  • Soybeans Post Gains with New Crop Leading Charge Amid Export Sales
    March 19, 2026, 2:53 AM EDT. Soybeans saw gains Wednesday, with prices rising 4 ¾ to 10 ¼ cents across front months. The new crop led advances as the soy/corn ratio neared 2.33, pushing the national average Cash Bean price up 5 cents to $10.87 3/4. Soymeal futures rose $4 to $10, while soy oil fell late, losing up to 44 points. A USDA report highlighted a private sale of 120,000 MT of soybean meal for 2026/27 to undisclosed buyers. The weekly Export Sales report, due Thursday, anticipates old crop sales between 350,000 and 800,000 MT and new crop sales up to 100,000 MT. Planting intentions survey estimates soybean acres at 85.66 million, up 4.46 million year-on-year. Futures prices reflect bullish sentiment as markets await USDA's March Intentions report on March 31.
Go toTop